The prevalence and contributing risk factors of coronavirus disease 2019 infection in patients with metabolic syndrome.

Bagheri-Hosseinabadi, Zahra; Moadab, Fatemeh; Amiri, Ali; Abbasifard, Mitra

Bagheri-Hosseinabadi, Zahra; Moadab, Fatemeh; Amiri, Ali; Abbasifard, Mitra.

Afiliação

Bagheri-Hosseinabadi Z; Molecular Medicine Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Moadab F; Department of Clinical Biochemistry, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Amiri A; Student Research Committee, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Abbasifard M; Immunology of Infectious Diseases Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.

BMC Endocr Disord ; 23(1): 100, 2023 May 04.

Article em En | MEDLINE | ID: mdl-37142990

Assuntos

COVID-19; Dislipidemias; Síndrome Metabólica; Humanos; Síndrome Metabólica/complicações; Síndrome Metabólica/epidemiologia; Prevalência; COVID-19/complicações; COVID-19/epidemiologia; SARS-CoV-2; Fatores de Risco; Obesidade/complicações; Obesidade/epidemiologia; Dislipidemias/epidemiologia; Dislipidemias/complicações

Palavras-chave

Coronavirus disease 2019; Infection susceptibility; Metabolic syndrome; Severe acute respiratory syndrome coronavirus 2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome Metabólica / Dislipidemias / COVID-19 Tipo de estudo: Etiology_studies / Prevalence_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google